We report the pharmacokinetic parameters of Clarith dry syrup 10% for pediatric in upper respiratory tract infection. Six subjects - 5 boys and 1 girl, age 6-10 (7.3 ± 1.6) years and having upper respiratory tract infection were treated with a 5 mg (potency)/kg oral dose of clarithromycin (CAM). Each had 6 blood samples taken with a 6 h period after CAM administration. Based on high-performance liquid chromatog. combined with an electrochem. detector (ECD-HPLC), we quant. analyzed CAM and (14R)-14-hydroxy-CAM (M-5) in serum. The ratio against pharmacokinetic parameters was (1) for CAM, Cmax 1.05 ± 0.33 μg/mL, AUC 3.54 ± 1.14 μg/h/mL, and T1/2 1.78 ± 0.28 h, (2) for M-5, Cmax 0.98 ± 0.27 μg/mL, AUC 5.37 ± 1.68 μg/h/mL, and T1/2 3.17 ± 0.59 h.